Tag: Prescription Drugs

Improved progression-free survival seen for amivantamab-lazertinib versus osimertinib as first-line treatment

89 percent of cancer centers report that cancer drugs are in short supply, most often vinblastine, etoposide, and topotecan

Higher percentages of men and adults aged 35 to 49 years received medications for opioid use disorder

Significantly more patients had histologic response with benralizumab than placebo, but no significant difference seen in dysphagia symptoms

Significant improvements seen in histologic, endoscopic, and transcriptomic measures in higher-exposure dupilumab regimen

Patients with stage III resected colon cancer with PIK3CA gain-of-function mutations treated with celecoxib had improved DFS, OS

Significant overall survival benefit seen for Glofit-GemOx at primary and follow-up analysis

Fills for emergency contraceptives increased during the first year after Dobbs in states that became the most restrictive and comparison states

Reduction seen in monthly headache days, monthly migraine days, and acute medication use days

Decrease in Peak Pruritus Numeric Rating Scale for PN, chronic pruritus of unknown origin patients